3 posters presented in 2022
1 poster presented in 2019
3 posters presented in 2018
13 posters presented in 2017
2022
Kasujee, I, Diaz, C. Lambert, C.J., Montejo, E.M, Narayanan S. (2022). Patient Perception of Disease and Treatment Burden and New Treatment Preferences in Actinic Keratosis. Presented at ISPOR 2022. May 15-18, 2022. Washington, D.C.
Narayanan S. Commercial Payer and Rare Disease Patient Stakeholder Perspectives on Incorporation of Direct Patient Input on Value of Medicines in Payer Formulary Decision-Making Process in the U.S. Poster Presentation at ISPOR 2022, May 15-18, 2022, Washington, D.C, USA.
Kasujee I, Gallo CD, Lambert CJ, Montejo EM, Narayanan S. Patient Perception of Disease and Treatment Burden and New Treatment Preferences in Actinic Keratosis. Poster Presentation at ISPOR 2022, May 15-18, 2022, Washington, D.C, USA.
2019
Reeves S, Narayanan S, Casanova C. Treatment switching and Perception of Physician Interactions in Rheumatoid Arthritis: Patient Perspectives. Poster Presentation at ISPOR 2019, May 18-22, 2019, New Orleans, USA.
2018
Kamat J, Gupta J, Gupta P, Narayanan S. The Clinical, Humanistic, and Economic Burden of Adenosine Deaminase (ADA) Severe Combined Immunodeficiency (SCID): A Systematic Literature Review. Poster Presentation at ISPOR Europe 2018, November 10-14, 2018, Barcelona, Spain.
Patel R, Kumar J, Gupta J, Narayanan S. Humanistic and Economic Burden Of X-Linked Hypophosphatemia (XLH): A Systematic Literature Review. Poster Presentation at ISPOR Europe 2018, November 10-14, 2018, Barcelona, Spain.
Carlton R, Regan T, Narayanan S. The Budget Impact Of Deflazacort For The Treatment Of Duchenne Muscular Dystrophy (DMD). Poster Presentation at ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, USA.
2017
Narayanan S, Olesen D. Diagnosis Of Patients With Duchenne Muscular Dystrophy (DMD): Results From A Global Survey Of Healthcare Providers From Nine Countries. Poster Presentation at ISPOR 20th Annual European Congress, Nov 4-8, 2017, Glasgow, UK.
Narayanan S, Olesen D. Management Of Duchenne Muscular Dystrophy (DMD): Results From A Global Survey Of Healthcare Providers From Nine Countries. Poster Presentation at ISPOR 20th Annual European Congress, Nov 4-8, 2017, Glasgow, UK.
Signorovitch J, Narayanan S, Sajeev G, Jin F, Elfring G, Souza M, McDonnell E, Yao Z, Darras B, Shieh P, McDonald C. Deflazacort or prednisone treatment for Duchenne muscular dystrophy: a meta-analysis of disease progression rates in recent multicenter clinical trials. Poster Presentation at ISPOR 20th Annual European Congress, Nov 4-8, 2017, Glasgow, UK.
Narayanan S, Souza M. Dosing Patterns Associated With Deflazacort Use In Duchenne Muscular Dystrophy (DMD): Observations From Deflazacort Early Access Program (EAP) In The U.S. Poster Presentation at ISPOR 20th Annual European Congress, Nov 4-8, 2017, Glasgow, UK
Narayanan S, Jin F, Souza M, Shao D, Gala S, Elfring G, Trifillis P, Ong T, Peltz SW, Darras BT, Shieh PB. Disease Burden and Treatment Landscape in Duchenne Muscular Dystrophy (DMD) in the United States. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Narayanan S, Gala S. Burden of Merkel Cell Carcinoma: A Targeted Literature Review. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Narayanan S, Mainz JG, Gala S, Tabori H, Grossoehme D. Targeted Literature Review Of Adherence To Therapies In Cystic Fibrosis (CF). Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Narayanan S, Shah A, Shao H, Ramesh V. Use of intermediate clinical endpoints as a primary efficacy endpoint in malignant melanoma. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Ramesh V, Shao H, Narayanan S. Clinical And Economic Assessment Of Diffuse Large B-Cell Lymphoma (DLBCL) Therapies Using A Proprietary Value Assessment Platform. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Black J, Shah S, Narayanan S. Identifying The Highest Business Opportunity For Future Development Among Key Patient Subgroups In Non-Small Cell Lung Cancer. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Black J, Ramesh V, Shao H, Shah S, Narayanan S. Conceptualization Of An Excel-Based Indication-Specific Pricing Model To Assess Potential Savings To A U.S. Health Plan. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Shah A, Narayanan S. Age-specific economic burden of respiratory syncytial virus (RSV) hospitalizations in the United States, 2009-2013: an analysis of Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
Shah A, Narayanan S. Clinical and Economic burden of acquired hemophilia among hospitalized patients in the US using Healthcare Cost and Utilization Project. Poster Presentation at ISPOR 22nd Annual Meeting, May 20-24, 2017, Boston, USA.
To request more information, send us an email at info@avant-health.com